Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 26,17 € (+28,10%). La mediana è 25,40 € (+24,33%).
| Acquista |
29 |
| Mantieni |
10 |
| Vendi |
0 |
Discussioni nella community
Non ci sono ancora discussioni su questo asset.
Avvia discussioneNotizie Vai al feed delle notizie
Chewy shifts growth focus to pet health, AI and clinics
Chewy is prioritizing U.S. pet health services—pharmacy, supplements, prescription diets, insurance, telemedicine and veterinary clinics—as its next growth engine while leveraging Autoship, mobile engagement and AI. About one-quarter of customers buy from Chewy Pharmacy, and pharmacy customers add roughly $300–$500 in annual spending; the company operates 60 clinics that are outperforming expectations. Chewy targets 150,000–250,000 net active-customer additions and aims for long-term high-single-digit to low-double-digit revenue growth, planning to self-fund investments and seek about $50 million in AI savings in 2027. Acquisition focus will be health-first, with international expansion a lower priority. » Altro su finance.yahoo.com
Chewy bets on health, AI and clinics as growth drivers
At the Goldman Sachs conference, Chewy announced plans to evolve from a pure pet-supplies retailer into a comprehensive pet-health platform, increasing investment in AI, veterinary clinics and pharmacies. Gross margin has risen from 18% at IPO to around 30%, driven by Autoship, the health business and supply-chain optimizations. Chewy now operates about 60 clinics, plans expansion through acquisitions such as Modern Animal, and intends to use AI tools (Chewy AI) and agentic commerce to boost customer retention and efficiency. Management expects to fund many growth investments from the core business, aims for further margin improvement and is also considering opportunistic M&A in the health sector. » Altro su de.investing.com
Chewy faces slowdown and margin questions after mixed Q2 beat and 48% slide
Chewy reported Q2 sales up 7.3% to $3.33 billion, adjusted EPS $0.36 and raised its full-year outlook, but organic revenue growth slowed to 5.7% and adjusted EBITDA outperformance relied on one-time items. Analysts cut ratings and price targets, with Evercore ISI downgrading to In Line amid concerns about a lack of clear growth catalysts and competitive pressure from Amazon and Walmart. The stock has fallen about 48% from its 52-week high and trades near multi-year lows; the report says the shares are only attractive if deceleration proves cyclical and future quarters show organic reacceleration and sustainable margin expansion. » Altro su finance.yahoo.com
JPMorgan downgrades Chewy and cuts price target to $24
JPMorgan downgraded Chewy from “Overweight” to “Neutral” and cut its price target from $29 to $24, after which the stock fell about 3.3%. Analyst Doug Anmuth cited persistent macroeconomic headwinds weighing on organic growth and sales of non‑essential products. Chewy gained market share despite the environment, reported a net increase of 208,000 active customers, raised its full‑year revenue outlook in the middle of the range by roughly $40 million, but does not see a meaningful recovery in consumer behavior in 2026; the improved EBITDA margin for the quarter was largely due to one‑off gross margin benefits of about $15 million. » Altro su de.investing.com
JPMorgan downgrades Chewy to neutral over tepid organic demand
JPMorgan has downgraded Chewy from "Overweight" to "Neutral", citing persistent macroeconomic pressure on organic growth as the main reason. Analyst Doug Anmuth sets a $24 price target for December 2027, based on roughly seven times the estimated adjusted EBITDA of $1.2 billion for 2028. Chewy fell about 9% after quarterly results but continues to gain market share and reports robust customer metrics; the quarter's margin strength was largely driven by one-off effects. JPMorgan praises acquisitions (SmartPak, Modern Animal), AI initiatives and share buybacks, but views the growth outlook as more subdued. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | agosto 2026 | YoY |
|---|---|---|
| Ricavi | 2,88 Mld | 7,68% |
| Utile lordo | 875,99 Mln | 7,72% |
| Utile netto | 69,74 Mln | 30,32% |
| EBITDA | 138,52 Mln | 49,29% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 8,21 Mld € |
Numero di azioni | 401,93 Mln |
Massimo/minimo a 52 settimane | 33,87 € - 15,78 € |
| Dividendi | No |
Beta | 1,33 |
Rapporto P/E | 34,12 |
Rapporto PEG | 0,44 |
Rapporto P/B | 24,70 |
Rapporto P/S | 0,69 |
Profilo aziendale
Chewy, Inc., insieme alle sue controllate, opera nel settore dell'e-commerce puro negli Stati Uniti. L'azienda offre cibo e snack per animali, prodotti per la cura degli animali, farmaci per animali e altri prodotti per la salute degli animali, nonché servizi per cani, gatti, pesci, uccelli, piccoli animali, cavalli e rettili tramite il sito di vendita al dettaglio www.chewy.com e le sue applicazioni mobili. Offre circa 100.000 prodotti di 3.000 marchi partner. La società è stata fondata nel 2010 e ha sede a Dania Beach, in Florida.
| Nome | CHEWY INC. DL-,01 |
| CEO | Sumit Singh |
| Sede centrale | Plantation,
fl Stati Uniti |
| Sito web | |
| Settore | Beni voluttuari |
| Industria | Vendita al dettaglio specializzata |
| Quotazione in borsa | 14/06/2019 |
| Dipendenti | 18.000 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NYSE | CHWY |
Frankfurt | 3HH.F |
Düsseldorf | 3HH.DU |
München | 3HH.MU |
SIX | CHWY.SW |